Phase I Study of Taxol in Refractory Acute Myelogenous Leukemias Using a Weekly Schedule

Publisher： Karger

E-ISSN： 1421-9662|99|2|106-108

ISSN： 0001-5792

Source： Acta Haematologica, Vol.99, Iss.2, 1998-03, pp. : 106-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 281-287

Karger

Access to resources Recommend Favorite

Fatal Hepatic Veno-Occlusive Disease in a Phase I Study of Mylotarg and Troxatyl in Patients with Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 164-167

Karger

Access to resources Recommend Favorite

A Phase II Study of Irinotecan Alternated with a Weekly Schedule of Oxaliplatin, High-Dose Leucovorin and 48-Hour Infusion 5-Fluorouracil in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 371-378

Karger

Access to resources Recommend Favorite

A Phase II Study of Irinotecan Alternated with a Weekly Schedule of High-Dose Leucovorin and 48-Hour 5-Fluorouracil Infusion in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 209-215

Karger

Access to resources Recommend Favorite

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 10, 2015-10 ,pp. : 1717-1724

John Wiley & Sons Inc

Access to resources Recommend Favorite